{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190503",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "58562",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211996s000,212161s000lbl.pdf",
              "date": "20190503",
              "type": "Label"
            },
            {
              "id": "58669",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211996Orig1s000, 212161Orig1s000ltr.pdf",
              "date": "20190612",
              "type": "Letter"
            },
            {
              "id": "59056",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211996Orig1s000,%20212161Orig1s000TOC.html",
              "date": "20190613",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20231017",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75876",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf",
              "date": "20231020",
              "type": "Label"
            },
            {
              "id": "75878",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/211996Orig1s002; 212161Orig1s002ltr.pdf",
              "date": "20231020",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210601",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "67648",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/211996Orig1s001;212161Orig1s001ltr.pdf",
              "date": "20210602",
              "type": "Letter"
            },
            {
              "id": "67667",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211996s001,212161s001lbl.pdf",
              "date": "20210603",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA211996",
      "sponsor_name": "FOLDRX PHARMS",
      "openfda": {
        "application_number": [
          "NDA211996"
        ],
        "brand_name": [
          "VYNDAQEL"
        ],
        "generic_name": [
          "TAFAMIDIS MEGLUMINE"
        ],
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "product_ndc": [
          "0069-1975",
          "0069-8730"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TAFAMIDIS MEGLUMINE"
        ],
        "spl_id": [
          "67f1031d-c298-4cf9-9051-bb8f99e56442"
        ],
        "spl_set_id": [
          "1b4121ee-a733-4456-a917-be2603477839"
        ],
        "package_ndc": [
          "0069-1975-12",
          "0069-1975-40",
          "0069-8730-01",
          "0069-8730-30"
        ],
        "unii": [
          "8FG9H9D31J",
          "ZU7CF08A1A"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VYNDAQEL",
          "active_ingredients": [
            {
              "name": "TAFAMIDIS MEGLUMINE",
              "strength": "20MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}